Clinical trials
Recruiting Inflammation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
129 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 15 |
| 2022 | 11 |
| 2023 | 12 |
| 2024 | 18 |
| 2025 | 30 |
| 2026 | 25 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 129 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| University of California, Davis | 4 |
| VA Office of Research and Development | 4 |
| Emory University | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| National Institute of Mental Health (NIMH) | 3 |
| University of California, Los Angeles | 3 |
| University of Colorado, Denver | 3 |
| University of North Carolina, Chapel Hill | 3 |
| Washington University School of Medicine | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 129 |
| Cognitive Dysfunction | 7 |
| Infections | 7 |
| Obesity | 7 |
| Overweight | 5 |
| Alzheimer Disease | 4 |
| Major Depressive Disorder | 4 |
| Metabolic Diseases | 4 |
| Metabolic Syndrome | 4 |
| Prediabetic State | 4 |
Trials
Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.
29 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.